Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

This study has been completed.

Study NCT00083005 Information provided by National Cancer Institute (NCI)

First Received: May 14, 2004 Last Updated: December 13, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)